Drug therapy for benign prostatic hyperplasia and individualized drug regime

VernacularTitle:良性前列腺增生症的药物治疗及个体化用药
Author: Yongfang LEI ¹ ; Qing LING
Author Information

1. 华中科技大学同济医学院附属同济医院药学部
Keywords: benign prostatic hyperplasia (BPH); drug therapy; personalized medicine
From: Journal of Pharmaceutical Practice 2017;35(5):447-448,456
CountryChina
Language:Chinese
Abstract: Objective To review the drug therapies for benign prostatic hyperplasia (BPH) and provide a reference for clinical individualized medication regime.Methods The mechanisms and clinical indications of commonly used BPH medications and some new drugs were discussed.The challenges for BPH therapies were also explored.Results α-receptor inhibitors and 5α-reductase inhibitors have the best effect for BPH.Surgery is needed for the BPH patients who are not responsive to the drug therapy.Conclusion Individualized medication programs reduce the medication waste and give patients the best treatment options.